The impact of inherited thrombophilia on liver transplantation

Transplantation

Volumn 87, Issue 7, 2009, Pages 1103-1104

  Spaggiari, Mario ^a   Di Benedetto, Fabrizio ^a   Masetti, Michele ^a   Ballarin, Roberto ^a   Romano, Antonio ^a   Pietrangelo, Antonello ^a   Gerunda, Giorgio Enrico ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; WARFARIN; ANTICOAGULANT AGENT;

ACTIVATED PROTEIN C RESISTANCE; ADULT; BLOOD CLOTTING TEST; CASE REPORT; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LIVER TRANSPLANTATION; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOPHILIA; THROMBOSIS; AGED; BLOOD CLOTTING; BRAIN HEMORRHAGE; DONOR; GENETICS; HEMOCHROMATOSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MIDDLE AGED; WILSON DISEASE;

AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; CARCINOMA, HEPATOCELLULAR; CEREBRAL HEMORRHAGE; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; THROMBOPHILIA; TISSUE DONORS;

EID: 65549133273     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819d40e4     Document Type: Letter

References (10)

1. Mateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-Results of the Spanish Multicentric Study on Thrombophilia (EMETStudy). Thromb Haemost 1997; 77: 444.
2. Loew A, Jacob D, Neuhaus P, et al. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. Transplantation 2005; 79: 1422.
3. Taylor MC, Greig PD, Detsky AS, et al. Factors associated with the high cost of liver transplantation in adults. Can J Surg 2002; 45: 425.
4. Brown RS Jr, Ascher NL, Lake JR, et al. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg 1997; 132: 1098.
5. Whiting JF, Martin J, Zavala E, et al. The influence of clinical variables on hospital costs after orthotopic liver transplantation. Surgery 1999; 125: 217.
6. Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden: A review. Arch Pathol Lab Med 2007; 131: 866.
7. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome. Transplantation 2000; 69: 1873.
8. MacLean RM, Feeney GP, Bowley SJ, et al. FactorVLeiden and the common haemochromatosis mutation HFE C282Y: Is there an association in familial venous thromboembolic disease? Br J Haematol 1999; 107: 210.
9. Xie YG, Lillicrap DP, Taylor SA. An association between the common hereditary hemochromatosis mutation and the factor V Leiden allele in a population with thrombosis. Blood. 1998; 92: 1461.
10. Tracy PB, Eide LL, Bowie EJ, et al. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59.